loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 208147 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE (1)

filter

01 TRIS PHARMA INC (1)

filter

01 SUSPENSION, EXTENDED RELEASE;ORAL (1)

filter

01 2MG/ML;EQ 0.5MG BASE/ML (1)

filter

01 USA (1)

URL Supplier Web Content
SUSPENSION, EXTENDED R...
2MG/ML;EQ 0.5MG BASE/M...
DYANAVEL XR
USA
208147
2015-10-19
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 208147

Looking for CTD TGA MCC DOSSIER APPLICATION 208147 1

19

Tris Pharma Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE, with a corresponding application number 208147 and regulatory information .

proudly manufactured in the

approval since 2015-10-19

Tris Pharma Inc's DYANAVEL XR SUSPENSION, EXTENDED RELEASE;ORAL, medication with 2MG/ML;EQ 0.5MG BASE/ML of AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE.

Post Enquiry
POST ENQUIRY